|
Match
|
Document |
Document Title |
|
|
7247652 |
β-benzyloxyaspartate derivatives with amino group on benzene ring
L-threo-β-benzyloxyaspartate derivatives having a substituent on the benzene ring, represented by the following formula (1):
wherein R is hydrogen, a linear or branched lower aliphatic acyl...
|
|
|
RE39734 |
Nutritional or therapeutic compositions to increase bodily glutathione levels
Nutritional or therapeutic compositions containing glutamic acid, cystine, glycine and a selenium precursor and methods for their utilization to increase glutathione synthesis and thereby enhance...
|
|
|
7241808 |
Composition for treatment of skin and method for stabilizing the composition
A composition for the treatment of skin comprises a carboxylated, acidic amino acid obtained by acidifying an acidic amino acid with a carboxylic acid. The resultant material, which is also...
|
|
|
7238503 |
Process for making fluoroleucine ethyl esters
The instant invention describes a novel reaction that includes spontaneous racemization of an azalactone via enol tautomerization. This racemization results in improved yield and ee over other...
|
|
|
7238727 |
Compositions for improving lipid metabolism
This invention aims at providing compositions and foods for improving lipid metabolism which improve the metabolism of lipids and thus are expected to contribute to the prevention and amelioration...
|
|
|
7235582 |
Basic salt of thioctic acid with L-carnitine
Salt of thioctic acid with L-carnitine with the formula:
AY(X) x
where A is
...
|
|
|
7220778 |
Methods and devices for epithelial protection during photodynamic therapy
Methods for preventing damage to epithelial tissue during PDT induced using a photosensitizing agent or pre-photosensitizing agent are provided. The methods of the present invention utilize spatial...
|
|
|
7220779 |
Swine growth promoters and method of promoting swine growth
A pig growth enhancer, which comprises, as an active ingredient, at least one compound selected from 5-aminolevulinic acid, a derivative thereof and a salt thereof, and a method for enhancing pig...
|
|
|
7220435 |
Process for the production of glycine enriched NaCI crystals with improved flow
The present invention relates to a simple, economical, and efficient cyclic process for producing rhombic dodecahedron shaped glycine enriched, free flowing common salt from brine, said process...
|
|
|
7217706 |
Propanolamine derivatives
This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]:
Wherein each symbol is as defined in the specification or salts thereof which...
|
|
|
7214709 |
Arginine/ascorbic acid mixed powder as an oral supplement
A mixture obtained by mixing ascorbic acid powder with arginine powder in a weight ratio (ascorbic acid/arginine) of 1/5 to 20, especially 1/5 to 1/4; and a supplement such as a nutrient...
|
|
|
7208523 |
Alanine- and glycine-containing therapeutic agent for hepatitis
The therapeutic agent for hepatitis, containing alanine and glycine, has only a slight toxicity and it can be administered either orally or intravenously to improve the liver function.
|
|
|
7199098 |
Copolymer-1 improvements in compositions of copolymers
The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.
|
|
|
7189747 |
Method of treating noninflammatory cartilage damage
The invention relates to a method of preventing or treating cartilage damage by administering a GABA analog such as, for example, a compound of Formula
and pharmaceutically acceptable salts...
|
|
|
RE39485 |
Oral Glutamine to reduce stomatitis
Glutamine is administered orally at a rate of about 4.5 g/m 2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis,...
|
|
|
7169812 |
Process for producing injectable gabapentin compositions
Injectable compositions containing gabapentin and processes for preparing sterile injectable compositions containing gabapentin are discussed. The process includes subjecting the compositions to...
|
|
|
7166641 |
Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
The present invention provides pharmaceutically acceptable salts having local anesthetic and anti-inflammatory activities. The preferred pharmaceutically acceptable salt is a diclofenac salt of...
|
|
|
7163956 |
Substituted fullerene compositions and their use as antioxidants
This patent discloses a substituted fullerenes, compositions comprising the same, and their use as antioxidants. The substituted fullerenes comprise a fullerene core (Cn) and at least one of: (i)...
|
|
|
7160913 |
Methods and kit for treating Parkinson's disease
The efficacy of levodopa therapy in patients being treated for Parkinson's disease is enhanced by administering high doses of a partial glycine agonist. The frequency and severity of...
|
|
|
7141552 |
Use of lipid conjugates in the treatment of diseases
The invention provides a method for treating a subject suffering from an intestinal disease, including, inter alia, Crohn's disease, ulcerative colitis, immuno-inflammatory intestinal injury,...
|
|
|
7141606 |
Gabapentin analogues for sleep disorders
The invention provides a new use of compounds for formula 1 or 1A or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of insomnia and related disorders.
|
|
|
7125882 |
Treatment of acne using alkonolamine compositions
Acne is treated or prevented by the topical application of compositions containing an alkanolamine such as dimethylaminoethanol, tyrosine, and a sulfur ingredient such as lipoic acid or...
|
|
|
7125909 |
Sterile parenteral nutrition compositions
Pharmaceutical compositions containing 2,6-diisopropylphenol (propofol) are described for use as anaesthetics. A method for their preparation is described, as their use in producing anaesthesia...
|
|
|
7122518 |
Method for preventing or reducing collateral phototoxic damage to neighboring tissues during photodynamic therapy of a target tissue
A method is provided for preventing or reducing the adverse effects of photodynamic therapy such as collateral damage by regulating the localized phototoxicity of an effector photosensitizer...
|
|
|
7112610 |
Methods for using amino acids with affinity for the α2δ-protein
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the...
|
|
|
7081479 |
Treatment of acne using alkonolamine compositions
Acne is treated or prevented by the topical application of compositions containing an alkanolamine such as dimethylaminoethanol, tyrosine, and a sulfur ingredient such as lipoic acid or...
|
|
|
7081481 |
Excitatory amino acid receptor modulators
Compounds of the formula (I) in which: R 1 is (CH 2 ) n Y; n is 1 or 2; Y is NHSO 2 R 2 or X 1 —W—X 2 —R 3 ; X 1 is O or NH; W is C═O, C═S, C═NH, or SO 2 ; X 2 is O or NH, provided...
|
|
|
7074418 |
Conjugated fatty acid based emulsion and methods for preparing and using same
Stable emulsions comprising as a base one or more diene conjugated fatty acids. Amino acids and other macromolecules can be used to stabilize the emulsion. The emulsion is also useful as a carrier...
|
|
|
7067545 |
Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
Remedies for spinocerebellar degeneration or compositions for treating the same which contain as the active ingredient one or more members selected from among D-cycloserine, D-serine esters,...
|
|
|
7063865 |
Composition and method for substantially reducing the deleterious effects of alcohol on the body
A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea,...
|
|
|
7064147 |
Amino acids with affinity for the α-2-delta-protein
This invention relates to certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. These compounds and their pharmaceutically acceptable salts are useful in the...
|
|
|
7056950 |
Compositions of biochemical compounds involved in bioenergy metabolism of cells
A composition of biochemical compounds involved in bioenergy metabolism of cells and a method of use in prevention and therapy of diseases are disclosed.
|
|
|
7056951 |
Stable solid dosage forms of amino acids and processes for producing same
Pharmaceutical formulations, and processes for making same, comprising an amino acid which is liable to formation of an undesirable lactam, and a stabilizer comprising a volatile alcohol; a...
|
|
|
7048918 |
Insect bait
Disclosed are insect baits for attracting insects such as ants, flies and cockroaches. The baits include amino acids and a sugar. The baits can be combined with an insect toxicant to effectively...
|
|
|
7045532 |
ACE-2 modulating compounds and methods of use thereof
ACE-2 inhibitors for the treatment of body weight and related disorders are disclosed. ACE-2 inhibitors include peptides and small molecules. Examples of small molecule ACE-2 inhibitors include...
|
|
|
7045549 |
Treatment of symptoms associated with irritable bowel syndrome
Methods are provided for use in treating humans suffering from irritable bowel syndrome. In the subject methods, an effective amount of a nerve-acting agent, e.g., lidocaine, topiramate, mexiletine...
|
|
|
7045152 |
Treating pulmonary disorders with gaseous agent causing repletion of GSNO
Pulmonary disorders in which the GSNO pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung as a gas,...
|
|
|
7022678 |
Pregabalin lactose conjugates
In accordance with the present invention, there is provided pregabalin lactose conjugate compounds. Also provided as part of the present invention is a novel method of central nervous system...
|
|
|
7022315 |
Administration of a thiol-based chemoprotectant compound
A method of administration of a thiol-based chemoprotectant agent including NAC (N-acetylcysteine) and STS (sodium thiosulfate) that markedly affects biodistribution and protects against injury...
|
|
|
7022737 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
Mammals are treated for infections or for conditions associated with pathologically proliferating mammalian cell growth by administration of a manipulator of nitrosative stress to selectively kill...
|
|
|
7011818 |
Carrier particles for use in dry powder inhalers
A powder for use in a dry powder inhaler includes active particles and carrier particles for carrying the active particles. The powder further includes additive material ( 4 ) on the surfaces of...
|
|
|
7012097 |
Anticancer agents based on prevention of protein prenylation
Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth....
|
|
|
7008963 |
Urushiol induced contact dermatitis solution
A solution for urushiol induced contact dermatitis is provided for in a topical solution. According to the invention, a method is provided for applying a composition of substances to the affected...
|
|
|
7005141 |
Oral drug delivery compositions and methods
The present invention relates to an oral drug delivery system, and in particular to modified amino acids and modified amino acid derivatives for use as a delivery system of sensitive agents such as...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6992109 |
Method for the treatment of incontinence
The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to treat incontinence.
|
|
|
6984389 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a...
|
|
|
6982097 |
Biocidal compositions and methods of using same
This invention relates to biocidal compositions and methods of using same. Also provided is a process for the manufacturing of a biocidal composition in the form of a tablet and a method of using...
|
|
|
6974833 |
Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
Methods for the treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as degenerative diseases atheriosclerosis, cancer, infection or other...
|
|
|
6967206 |
Compositions and methods for increasing growth hormone levels
A composition for increasing GH levels in a mammal including effective amounts of huperzine A and secretagogue amino acids and methods thereof.
|